Germany Pharmacy Market Analysis


  • Type: Service area
  • Published : April 2021
  • Region: Europe
  • Country: Germany
  • Report ID : 2063

  • Format: PPT, PDF

Germany Pharmacy Market: Segmented by Drug Class & Application – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 2063 Categories: ,

Report Overview

Germany’s Pharmacy market size stood at around USD 41.4 billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX.X% during the forecast period.

Increasing patent applications that are focused on the development of novel drug delivery systems, new drugs, and formulations are anticipated to boost the market for pharmaceuticals. According to the European Patent Office (EPO) Patent Index 2019, the number of patent applications increased by 4.4% in 2018 in the pharmaceutical field. This growth in patent applications is estimated to accelerate innovations in the pharmaceutical industry.

Market Drivers

Along with increasing patent applications, the growing export of pharmaceuticals from the Federal Republic of Germany to various countries is anticipated to boost the growth of the market for pharmaceuticals. For instance, according to the German Pharmaceutical Industry Association (BPI), in 2018, pharmaceuticals worth USD 98.6 billion were exported from Germany.

This corresponds to an increase of 10.3% over the previous year. Furthermore, the U.S., Netherlands, and Switzerland are the top three main customers for pharmaceuticals from Germany. Favorable reimbursement scenario and pricing for pharmaceuticals companies &customers are expected to fuel the growth of the market for pharmaceuticals. For instance, in Germany, 90% of the population is covered by Statutory Health Insurance (SHI) and the remaining 10.0% is covered by special schemes and private insurance.

The presence of strong pipeline drugs in Phase III clinical trials is expected to be commercialized over the forecast period, thereby, driving the growth of the market for pharmaceuticals. For instance, Boehringer Ingelheim International GmbH’s R & D pipeline consists of two candidates namely Empagliflozin and Nintedanib under phase III clinical trial for cardiovascular diseases and respiratory diseases.

1. Germany Pharmacy Market Overview………………………………
A. Market Size
2. Market Drivers…………………..………………………………….………….
A. Increasing patent applications
B. Growing exports
3. Pharmacy Market Segmentation…………………………………
A. By Drug Class
a. Anti-cancer
b. Anti-diabetics
c. Anti-rheumatics
d. Vaccines
e. Anti-viral
f. Immunosuppressants
g. Bronchodilators
h. Dermatological
i. Anti-hypertensive
j. Others
B. By Application
a. Oncology
b. Infectious Diseases
c. Cardiovascular Diseases
d. Central Nervous System Disorders
e. Immunological Disorders
f. Metabolic Disorders
g. Gastrointestinal Disorders
h. Respiratory Diseases
i. Ophthalmology
j. Dermatology Disorders
k. Others
4. Major Products Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue
5. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
6. Key Company Profiles…………………………………………………………………..
A. Boehringer Ingelheim GmbH Company overview, Product & Services, Strategies & Financials
B. Bayer AG Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
8. Factors Driving Future Growth……………………………………………………
A. New Trends and Developments
9. Potential Market Opportunities…………………………………….
A. Current Market Opportunities
B. Future Market Opportunities
10. Conclusion

By Drug Class:

Germany Pharmacy market can be categorized based on drug class as:

    • Anti-cancer
    • Anti-diabetics
    • Anti-rheumatics
    • Vaccines
    • Anti-viral
    • Immunosuppressants
    • Bronchodilators
    • Dermatological
    • Anti-hypertensive
    • Others

The anti-cancer segment accounted for the largest revenue share of XX.X% in 2019 due to the increasing prevalence of cancer and the commercialization of novel therapies to treat various types of cancers. For instance, according to GLOBOCAN 2018, there were 71,888 new cases of breast cancer, followed by lung cancer with 66,749 new cases, and 62,641 new prostate cancer cases.

By Application:

Germany Pharmacy market can be categorized by application on various diseases as:

    • Oncology
    • Infectious diseases
    • Cardiovascular diseases
    • Central Nervous System Disorders
    • Immunological Disorders
    • Metabolic Disorders
    • Gastrointestinal Disorders
    • Respiratory Diseases
    • Ophthalmology
    • Dermatology Disorders
    • Others

Oncology accounted for the largest revenue share of 15.5% in 2019 owing to increasing strategic initiatives such as collaboration, partnership, & others to develop & strengthen their portfolio.

For instance, in September 2019, Boehringer Ingelheim International GmbH and Lupin Ltd entered a partnership to license, develop, and commercialize Lupin’s MEK inhibitor compound (LNP3794) for the treatment of cancers. Under the agreement, Boehringer Ingelheim will develop innovative KRAS inhibitors in combination with Lupin’s lead MEK inhibitor compound for gastrointestinal and lung cancers.

Major Players

Key players are focusing on the development and approval of new vaccines for infectious diseases to maintain a significant share in the market for pharmaceuticals in Germany. For instance, in November 2019, Merck Sharp and Dohme Corporation’s ERVEBO vaccine was approved by the EU Commission against the Zaire Ebola virus for people of age 18 years and above. Some of the prominent players in the German pharmaceuticals market include:

    • Boehringer Ingelheim International GmbH
    • Bayer AG
    • Merck & Co., Inc.
    • Fresenius Kabi AG
    • STADA Arzneimittel AG
    • Pfizer Inc
    • Abbott
    • Abbvie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements